Table 2.
Heading | All | Men | Women |
---|---|---|---|
3MST20 | N = 66 | N = 33 | N = 33 |
RHR (bpm) | 68.9 (9.7) | 66.2 (11.0) | 71.6 (7.4) * |
HR1 (bpm) | 109.5 (12.6) | 103.6 (10.1) | 115.4 (12.3) * |
HR2 (bpm) | 114.1 (14.6) | 105.8 (9.5) | 122.6 (14.3) * |
HR3 (bpm) | 116.7 (15.0) | 108.2 (9.8) | 125.3 (14.5) * |
HRR30s (bpm) | 94.1 (15.1) | 86.2 (11.4) | 101.9 (14.2) * |
HRR1 (bpm) | 81.1 (13.9) | 74.8 (12.2) | 87.4 (12.2) * |
%APMHR at the third minute of exercise | 62.8 (8.7) | 57.7 (5.9) | 67.8 (8.2) * |
3MST30 | N = 73 | N = 37 | N = 36 |
RHR (bpm) | 70.7 (10.7) | 67.4 (10.3) | 74.1 (10.2) * |
HR1 (bpm) | 121.6 (13.2) | 114.3 (8.6) | 129.1 (12.9) * |
HR2 (bpm) | 132.9 (15.6) | 122.3 (10.4) | 143.8 (12.2) * |
HR3 (bpm) | 137.5 (17.8) | 125.3 (10.9) | 150.0 (14.6) * |
HRR30s (bpm) | 112.9 (20.5) | 101.9 (14.9) | 124.3 (19.4) * |
HRR1 (bpm) | 96.5 (20.4) | 86.1 (15.0) | 107.1 (19.8) * |
%APMHR at the third minute of exercise | 73.9 (10.8) | 67.0 (7.2) | 81.1 (9.0) * |
Six-minute walk test | N = 64 | N = 32 | N = 32 |
Distance (m) | 715 (94.9) | 762.7 (97.2) | 667.4 (64.6) * |
Cardiopulmonary exercise test | N = 73 | N = 37 | N = 36 |
RHR (bpm) | 19.01 (1.1) | 19.0 (1.0) | 19.0 (1.2) |
HR at end of the test (bpm) | 188.8 (10.3) | 191.6 (8.7) | 185.9 (11.2) * |
%APMHR | 101.3 (5.5) | 102.3 (5.0) | 100.3 (5.8) |
Cessation stage (range) | 5.2 (3–6) | 5.7 (5–6) | 4.6 (3–6) |
VO2max (mL∙kg−1∙min−1) | 37.3 (8.8) | 42.8 (7.3) | 31.6 (6.3) * |
Note: 3MST20 = 3-min step test using 20.3-cm step box height; RHR = resting heart rate; bpm = beats per minute; HR1 = heart rate at 1 min; HR2 = heart rate at 2 min; HR3 = heart rate at 3 min; HRR30s = heart rate recovery at 30 s after cessation; HRR1 = heart rate recovery at 1 min after cessation; APMHR = age-predicted maximal heart rate; 3MST30 = 3-min step test using 30-cm step box height; HR = heart rate; VO2max = maximal oxygen consumption. Numerical variables are presented as means (standard deviations) and categorical variables as means (ranges). * Significant differences from the male participants, p < 0.05.